# Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome

> **NCT06030713** · NA · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 33 (actual)

## Conditions studied

- Microbial Colonization
- Antibiotic Side Effect
- Cesarean Section Complications

## Interventions

- **DRUG:** Cefazolin

## Key facts

- **NCT ID:** NCT06030713
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06030713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06030713, "Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06030713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*